Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.

about

Moving Beyond Serendipity to Mechanism-Driven Psychiatric Therapeutics.

P2860

Q53583551-8CD748B2-F0D3-4508-A770-0A911D5D9D9A

P2860

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.

Item

http://www.wikidata.org/entity/Q38687081

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Why Psychiatry Needs 3,4-Methy ...... ld Psychiatrist's Perspective.

@en

type

Item

label

Why Psychiatry Needs 3,4-Methy ...... ld Psychiatrist's Perspective.

@en

prefLabel

Why Psychiatry Needs 3,4-Methy ...... ld Psychiatrist's Perspective.

@en

P1476

Why Psychiatry Needs 3,4-Methy ...... ld Psychiatrist's Perspective.

@en

P2093

Ben Sessa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research.

Mindfulness-based therapies for substance use disorders: part 1.

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

Down will come baby, cradle and all: diagnostic and therapeutic implications of chronic trauma on child development.

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).

P2888

s13311-017-0531-1

P304

741-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S13311-017-0531-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28477247

http://www.w3.org/2001/XMLSchema#string

P921

amine

post-traumatic stress disorder

mechanism of action

P932

5509627

http://www.w3.org/2001/XMLSchema#string

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.

about

P2860

P2860

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932